Results 201 to 210 of about 57,705 (278)

Low‐dose testosterone administration and oestrogen synthase availability in the female brain: A pilot study

Journal of Neuroendocrinology, Volume 38, Issue 3, March 2026.
Abstract Testosterone and oestrogens play significant roles in female physiology, extending beyond reproductive functions to influence brain health, mood regulation, and behaviour. Testosterone low‐dose therapy is increasingly considered for alleviating sexual dysfunction symptoms in postmenopausal women, and has been recently investigated as therapy ...
Manon Dubol, My Jonasson, Kayo Takahashi, Johan Wikström, Yasuyoshi Watanabe, Gunnar Antoni, Mark Lubberink, Anat Biegon, Inger Sundström‐Poromaa, Erika Comasco   +9 more
wiley   +1 more source

Comparative efficacy of Palbociclib and Everolimus with aromatase inhibitors in second line treatment of HR and HER2 negative metastatic breast cancer. [PDF]

Discov Oncol
Najafizade N, Zarei S, Elhaie M, Roayaei M.   +3 more
europepmc   +1 more source

Adaptive Changes Result in Activation of Alternate Signaling Pathways and Acquisition of Resistance to Aromatase Inhibitors [PDF]

, 2011
Angela Brodie, Gauri Sabnis
openalex   +1 more source

Effects of gonadectomy on brain sex hormone levels and amyloid pathology in male and female AppNL‐G‐F and AppNL‐F mice

Journal of Neuroendocrinology, Volume 38, Issue 3, March 2026.
Abstract More women than men are diagnosed with Alzheimer's disease (AD). Sex hormones have been ascribed neuroprotective properties, and their decline, particularly the reduction of estrogen during menopause, has been implicated in AD risk. In this study, we examined how loss of circulating sex hormones affects cognitive performance and amyloid ...
Patricia Muñoz, Heba G. Ali, Aphrodite Demetriou, Maria Latorre‐Leal, Makoto Shimozawa, Ljerka Delac, Tudor‐Fabian Troncea‐Sandu, Jose Inzunza, Per Nilsson, Silvia Maioli, Ivan Nalvarte   +10 more
wiley   +1 more source

A Randomized Controlled Trial of Hypnosis to Manage Musculoskeletal Pain in Breast Cancer Survivors Taking Aromatase Inhibitors. [PDF]

Psychol Conscious (Wash D C)
Montgomery GH, Schnur JB, Tiersten A, Benck K, Erblich J.   +4 more
europepmc   +1 more source

Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors

, 2010
Yujie Dai, Qiang Wang, Xiuli Zhang, Shiru Jia, Heng Zheng, Dacheng Feng, Peng Yu   +6 more
openalex   +1 more source

Supplementary Table 6 from Genome-Wide Analysis of Aromatase Inhibitor-Resistant, Tamoxifen-Resistant, and Long-Term Estrogen-Deprived Cells Reveals a Role for Estrogen Receptor

, 2023
Selma Masri, Sheryl Phung, Xin Wang, Xiwei Wu, Yate‐Ching Yuan, Lawrence D. Wagman, Shiuan Chen   +6 more
openalex   +1 more source

Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management. [PDF]

Cancers (Basel)
Nardin S, Ruffilli B, Landolfo TL, Isingrini G, Taglialatela I, Delbarba A, D'Avanzo F, Rossi V, Celentano E, Conte B, Nardin M, Gennari A.   +11 more
europepmc   +1 more source

The Incidence and Severity of Adverse Effects Associated with Different Types of Aromatase Inhibitor Prescribed in Patients with Breast Cancer

, 2009
Ashrf L. Habib, Moheb Basta, Andrew A. R. Andrawes   +2 more
openalex   +1 more source

Alfacalcidol prevents aromatase inhibitor (Letrozole)-induced bone mineral loss in young growing female rats [PDF]

, 2009
Idris Mohamed, James K. Yeh
openalex   +1 more source